3Sael-Royula F,Pores JC,Moreno A,et al.High doas ofrecombdrit a-Interfron and Y-Interfron for chronic hepatitisC=a Randomized controlied trial. Hepatology . 1991
4Mallat A,Preaux AM,Blazejewski S,et al.Interferon aira andganuna allbit proliferation and collagen sythesis of human itocells in culture. Hepatology . 1995
5Ducan MR.ffernan B Y-Interferon is the lymphokine and 9-inerferon the monokine responsible for inhibition of fibroblastcollagen preduction and late but not early fibroblast proliferation. The Journal of Experimental Medicine .
6Hogemann B,Demschke W.Hepatic Fibrosis - currentconecpts of pathogensis and therapy. Gastroenterologia Japonica . 1993
7Ehas I,Alptal G. Gubba S,et al.Antiprolifration effects ofIFN - Y in CCl4 - induced cirrhosis. Hepatology . 1995
8Murawaki Y,Kusakabe Y,Hirayma C.Seruznlysyl ohoase activity in chronic liver disease in comparison with serum levels ofprolyl hydroxylase and Iaminin. Hepatology .
9Wu J.Ichbition of hepatic fibrogensis: a review of pharmacologic candidates. Scandinavian Journal of Gastroenterology .
10Roulot D,Durand H,Coste T,et al.Quantitative analysis oftransforming growth factor B1 messenger RNA in the liver ofpatients with chronic hepatitis C: absence of correlation betweenhigh levels and severity of disease. Hepatology .
